Articles - Press

Ayurvedic Drug Misails for Target Disease
Murgude MM*, Salunkhe VR, Magdum CS and Thorat SA
Abstract |  Full Text |  PDF
Changes in Skin Morphology Based on Hormonal and Anatomical Differences
Ekta Yadav*, Katherine Vanta and Niket Yadav
Abstract |  Full Text |  PDF
Fresh Perspective on Costs of the Glucagon-Like-Peptide-1 Relative to Anti-Cancer Drugs
Helmy M Guirgis*
Abstract |  Full Text |  PDF
Cost Comparison of the Bispecific Ivonescimab, Immune Check Point Inhibitors and Target Therapy in advanced/metastatic Lung Cancer
Helmy M Guirgis*
Abstract |  Full Text |  PDF
Cost Class Comparison of Anti-Cancer Therapy vs Glucagon-Like- Peptide-1 for Diabetes Mellitus and Anti-Plaque for Alzheimer
Helmy M Guirgis*
Abstract |  Full Text |  PDF
Costs of Extended Drug Treatment Duration in Multiple Diseases
Helmy M Guirgis*
Abstract |  Full Text |  PDF
The Bispecific Ivonescimab and the Immune Check Point Inhibitor Durvalumab in Lung Cancer: Cost Consideration
Helmy M Guirgis*
Abstract |  Full Text |  PDF